UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000012030
Receipt number R000014061
Scientific Title A Phase II study of pertuzumab+trastuzumab+capecitabine in Patients with taxans and trastuzumab refractory for advanced or recurrent breast cancer
Date of disclosure of the study information 2013/10/15
Last modified on 2017/11/30 18:10:03

No. Disposal Last modified on Item of update
1 Insert 2013/10/14 16:23:26
2 Update 2017/11/30 18:10:03 UMIN ID1